Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diseases of the Thyroid

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 62 articles:
HTML format
Text format



Single Articles


    January 2018
  1. WU H, Zhang B, Li J, Liu Q, et al
    Echogenic foci with comet-tail artifact in resected thyroid nodules: Not an absolute predictor of benign disease.
    PLoS One. 2018;13:e0191505.
    PubMed     Text format     Abstract available


  2. THVILUM M, Brandt F, Brix TH, Hegedus L, et al
    No evidence of a causal relationship between hypothyroidism and glaucoma: A Danish nationwide register-based cohort study.
    PLoS One. 2018;13:e0192311.
    PubMed     Text format     Abstract available


  3. SEO JW, Han K, Lee J, Kim EK, et al
    Application of metabolomics in prediction of lymph node metastasis in papillary thyroid carcinoma.
    PLoS One. 2018;13:e0193883.
    PubMed     Text format     Abstract available


  4. YEH CC, Su FH, Tzeng CR, Muo CH, et al
    Women with adenomyosis are at higher risks of endometrial and thyroid cancers: A population-based historical cohort study.
    PLoS One. 2018;13:e0194011.
    PubMed     Text format     Abstract available


  5. JUNG YS, Oh CM, Kim Y, Jung KW, et al
    Long-term survival of patients with thyroid cancer according to the methods of tumor detection: A nationwide cohort study in Korea.
    PLoS One. 2018;13:e0194743.
    PubMed     Text format     Abstract available


  6. MIZUGUCHI Y, Morimoto S, Kimura S, Takano N, et al
    Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves' disease.
    PLoS One. 2018;13:e0195464.
    PubMed     Text format     Abstract available


  7. MASSOLT ET, Chaker L, Visser TJ, Gillis AJM, et al
    Serum microRNA profiles in athyroid patients on and off levothyroxine therapy.
    PLoS One. 2018;13:e0194259.
    PubMed     Text format     Abstract available


  8. PARK B, Min C, Choi HG
    Neck dissection does not increases the risk of stroke in thyroid cancer: A national cohort study.
    PLoS One. 2018;13:e0195074.
    PubMed     Text format     Abstract available


  9. GONG Y, Yang J, Wu W, Liu F, et al
    Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer.
    PLoS One. 2018;13:e0197007.
    PubMed     Text format     Abstract available


  10. SCHNEIDER C, Feller M, Bauer DC, Collet TH, et al
    Initial evaluation of thyroid dysfunction - Are simultaneous TSH and fT4 tests necessary?
    PLoS One. 2018;13:e0196631.
    PubMed     Text format     Abstract available


    January 2017
  11. JEONG H, Baek SY, Kim SW, Eun YH, et al
    Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.
    PLoS One. 2017;12:e0176260.
    PubMed     Text format     Abstract available


  12. CAMPO C, Kohler A, Figlioli G, Elisei R, et al
    Inherited variants in genes somatically mutated in thyroid cancer.
    PLoS One. 2017;12:e0174995.
    PubMed     Text format     Abstract available


  13. KIM SY, Lee E, Nam SJ, Kim EK, et al
    Ultrasound texture analysis: Association with lymph node metastasis of papillary thyroid microcarcinoma.
    PLoS One. 2017;12:e0176103.
    PubMed     Text format     Abstract available


  14. ZHANG Y, Wang H, Pan X, Teng W, et al
    Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0175708.
    PubMed     Text format     Abstract available


  15. AASS C, Norheim I, Eriksen EF, Bornick EC, et al
    Establishment of a tear protein biomarker panel differentiating between Graves' disease with or without orbitopathy.
    PLoS One. 2017;12:e0175274.
    PubMed     Text format     Abstract available


  16. CATALANI S, Palma F, Battistelli S, Benedetti S, et al
    Oxidative stress and apoptosis induction in human thyroid carcinoma cells exposed to the essential oil from Pistacia lentiscus aerial parts.
    PLoS One. 2017;12:e0172138.
    PubMed     Text format     Abstract available


  17. AMOUZEGAR A, Gharibzadeh S, Kazemian E, Mehran L, et al
    The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study.
    PLoS One. 2017;12:e0169283.
    PubMed     Text format     Abstract available


  18. KATAGIRI R, Yuan X, Kobayashi S, Sasaki S, et al
    Effect of excess iodine intake on thyroid diseases in different populations: A systematic review and meta-analyses including observational studies.
    PLoS One. 2017;12:e0173722.
    PubMed     Text format     Abstract available


  19. JOHNS LE, Ferguson KK, McElrath TF, Mukherjee B, et al
    Longitudinal Profiles of Thyroid Hormone Parameters in Pregnancy and Associations with Preterm Birth.
    PLoS One. 2017;12:e0169542.
    PubMed     Text format     Abstract available


  20. KIM Y, Kim MH, Jeon S, Kim J, et al
    Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma.
    PLoS One. 2017;12:e0174737.
    PubMed     Text format     Abstract available


  21. XIU L, Zhong G, Ma X
    Urinary iodine concentration (UIC) could be a promising biomarker for predicting goiter among school-age children: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0174095.
    PubMed     Text format     Abstract available


  22. KIM HI, Kim TH, Kim H, Kim YN, et al
    Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication.
    PLoS One. 2017;12:e0169775.
    PubMed     Text format     Abstract available


  23. XIA N, Ye X, Hu X, Song S, et al
    Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.
    PLoS One. 2017;12:e0174260.
    PubMed     Text format     Abstract available


  24. LIN JD, Lin SF, Chen ST, Hsueh C, et al
    Long-term follow-up of papillary and follicular thyroid carcinomas with bone metastasis.
    PLoS One. 2017;12:e0173354.
    PubMed     Text format     Abstract available


  25. LIN SF, Lin JD, Hsueh C, Chou TC, et al
    A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer.
    PLoS One. 2017;12:e0172315.
    PubMed     Text format     Abstract available


  26. ZHANG M, Qin Y, Zuo B, Gong W, et al
    Overexpression of NOTCH-regulated Ankyrin Repeat Protein is associated with papillary thyroid carcinoma progression.
    PLoS One. 2017;12:e0167782.
    PubMed     Text format     Abstract available


  27. LI Q, Ye H, Ding Y, Chen G, et al
    Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases.
    PLoS One. 2017;12:e0176064.
    PubMed     Text format     Abstract available


  28. FERNSTROM J, Westrin A, Grudet C, Traskman-Bendz L, et al
    Six autoantibodies associated with autoimmune encephalitis are not detectable in the cerebrospinal fluid of suicide attempters.
    PLoS One. 2017;12:e0176358.
    PubMed     Text format     Abstract available


  29. FRANCESCHI S, Lessi F, Panebianco F, Tantillo E, et al
    Loss of c-KIT expression in thyroid cancer cells.
    PLoS One. 2017;12:e0173913.
    PubMed     Text format     Abstract available


  30. PENG N, Shi L, Zhang Q, Hu Y, et al
    Microarray profiling of circular RNAs in human papillary thyroid carcinoma.
    PLoS One. 2017;12:e0170287.
    PubMed     Text format     Abstract available


  31. WANG C, Zhang X, Li H, Li X, et al
    Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis.
    PLoS One. 2017;12:e0179664.
    PubMed     Text format     Abstract available


  32. YUN JS, Bae JM, Kim KJ, Jung YS, et al
    Increased risk of thyroid diseases in patients with systemic lupus erythematosus: A nationwide population-based Study in Korea.
    PLoS One. 2017;12:e0179088.
    PubMed     Text format     Abstract available


  33. KRONBORG TM, Hansen JF, Rasmussen AK, Vorkamp K, et al
    The flame retardant DE-71 (a mixture of polybrominated diphenyl ethers) inhibits human differentiated thyroid cell function in vitro.
    PLoS One. 2017;12:e0179858.
    PubMed     Text format     Abstract available


  34. KOWALIK A, Kowalska A, Walczyk A, Chodurska R, et al
    Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications.
    PLoS One. 2017;12:e0179691.
    PubMed     Text format     Abstract available


  35. PARK YM, Lee SM, Kim DW, Shin SC, et al
    Predictive factors of right paraesophageal lymph node metastasis in papillary thyroid carcinoma: Single center experience and meta-analysis.
    PLoS One. 2017;12:e0177956.
    PubMed     Text format     Abstract available


  36. LUBITZ C, Ali A, Zhan T, Heberle C, et al
    The thyroid cancer policy model: A mathematical simulation model of papillary thyroid carcinoma in The U.S. population.
    PLoS One. 2017;12:e0177068.
    PubMed     Text format     Abstract available


  37. CHOW LQ, Santana-Davila R, Pantel A, Roth M, et al
    A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine.
    PLoS One. 2017;12:e0178325.
    PubMed     Text format     Abstract available


  38. JEGERLEHNER S, Bulliard JL, Aujesky D, Rodondi N, et al
    Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study.
    PLoS One. 2017;12:e0179387.
    PubMed     Text format     Abstract available


  39. YANG D, Wang C, Luo Y, Li X, et al
    Activated E2F activity induces cell death in papillary thyroid carcinoma K1 cells with enhanced Wnt signaling.
    PLoS One. 2017;12:e0178908.
    PubMed     Text format     Abstract available


  40. KANG YY, Liu Y, Wang ML, Guo M, et al
    Construction and analyses of the microRNA-target gene differential regulatory network in thyroid carcinoma.
    PLoS One. 2017;12:e0178331.
    PubMed     Text format     Abstract available


  41. KIM H, Kim TH, Kim HI, Park SY, et al
    Subclinical thyroid dysfunction and risk of carotid atherosclerosis.
    PLoS One. 2017;12:e0182090.
    PubMed     Text format     Abstract available


  42. WANG Y, Brule E, Silander T, Bak B, et al
    The short mRNA isoform of the immunoglobulin superfamily, member 1 gene encodes an intracellular glycoprotein.
    PLoS One. 2017;12:e0180731.
    PubMed     Text format     Abstract available


  43. BUFFET C, Hecale-Perlemoine K, Bricaire L, Dumont F, et al
    DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers.
    PLoS One. 2017;12:e0184861.
    PubMed     Text format     Abstract available


  44. KHATAMI F, Larijani B, Heshmat R, Keshtkar A, et al
    Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer.
    PLoS One. 2017;12:e0184892.
    PubMed     Text format     Abstract available


  45. MEI D, Lv B, Chen B, Xiao S, et al
    All-trans retinoic acid suppresses malignant characteristics of CD133-positive thyroid cancer stem cells and induces apoptosis.
    PLoS One. 2017;12:e0182835.
    PubMed     Text format     Abstract available


  46. WANG L, Cao F, Wang S, Sun M, et al
    Using k-dependence causal forest to mine the most significant dependency relationships among clinical variables for thyroid disease diagnosis.
    PLoS One. 2017;12:e0182070.
    PubMed     Text format     Abstract available


  47. GHOLAMPOUR DEHAKI M, Amouzegar A, Delshad H, Mehrabi Y, et al
    Thyroid dysfunction in patients with impaired glucose metabolism: 11 year follow up from the Tehran Thyroid Study.
    PLoS One. 2017;12:e0184808.
    PubMed     Text format     Abstract available


  48. LIN JD, Yang SF, Wang YH, Fang WF, et al
    Associations of melatonin receptor gene polymorphisms with Graves' disease.
    PLoS One. 2017;12:e0185529.
    PubMed     Text format     Abstract available


  49. WANG S, Liu Y, Zheng G
    Hypothyroidism as a risk factor for open angle glaucoma: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0186634.
    PubMed     Text format     Abstract available


  50. NAM SJ, Kwak JY, Moon HJ, Yoon JH, et al
    Large (>/=3cm) thyroid nodules with benign cytology: Can Thyroid Imaging Reporting and Data System (TIRADS) help predict false-negative cytology?
    PLoS One. 2017;12:e0186242.
    PubMed     Text format     Abstract available


  51. HOERMANN R, Midgley JEM, Larisch R, Dietrich JWC, et al
    Advances in applied homeostatic modelling of the relationship between thyrotropin and free thyroxine.
    PLoS One. 2017;12:e0187232.
    PubMed     Text format     Abstract available


  52. HE C, Ma J, Jiang Y, Su X, et al
    Associations between RET tagSNPs and their haplotypes and susceptibility, clinical severity, and thyroid function in patients with differentiated thyroid cancer.
    PLoS One. 2017;12:e0187968.
    PubMed     Text format     Abstract available


  53. LOZANO-VELASCO E, Wangensteen R, Quesada A, Garcia-Padilla C, et al
    Hyperthyroidism, but not hypertension, impairs PITX2 expression leading to Wnt-microRNA-ion channel remodeling.
    PLoS One. 2017;12:e0188473.
    PubMed     Text format     Abstract available


  54. GOLBERT L, de Cristo AP, Faccin CS, Farenzena M, et al
    Serum TSH levels as a predictor of malignancy in thyroid nodules: A prospective study.
    PLoS One. 2017;12:e0188123.
    PubMed     Text format     Abstract available


  55. PANG T, Huang L, Deng Y, Wang T, et al
    Logistic regression analysis of conventional ultrasonography, strain elastosonography, and contrast-enhanced ultrasound characteristics for the differentiation of benign and malignant thyroid nodules.
    PLoS One. 2017;12:e0188987.
    PubMed     Text format     Abstract available


    January 2016
  56. GAO X, Liu M, Qu A, Chen Z, et al
    Native Magnetic Resonance T1-Mapping Identifies Diffuse Myocardial Injury in Hypothyroidism.
    PLoS One. 2016;11:e0151266.
    PubMed     Text format     Abstract available


  57. TING WH, Chien MN, Lo FS, Wang CH, et al
    Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.
    PLoS One. 2016;11:e0154394.
    PubMed     Text format     Abstract available


  58. AHMED RH, Huri HZ, Al-Hamodi Z, Salem SD, et al
    Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects.
    PLoS One. 2016;11:e0154369.
    PubMed     Text format     Abstract available


  59. CHOI J, Kim JW, Keum YS, Lee IJ, et al
    The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups.
    PLoS One. 2016;11:e0154739.
    PubMed     Text format     Abstract available


  60. YU J, Tian AJ, Yuan X, Cheng XX, et al
    Subclinical Hypothyroidism after 131I-Treatment of Graves' Disease: A Risk Factor for Depression?
    PLoS One. 2016;11:e0154846.
    PubMed     Text format     Abstract available


  61. ZHAO Z, Zou J, Zhao L, Cheng Y, et al
    Celiac Disease Autoimmunity in Patients with Autoimmune Diabetes and Thyroid Disease among Chinese Population.
    PLoS One. 2016;11:e0157510.
    PubMed     Text format     Abstract available


  62. CIAPPUCCINI R, Aide N, Blanchard D, Rame JP, et al
    Incremental Value of a Dedicated Head and Neck Acquisition during 18F-FDG PET/CT in Patients with Differentiated Thyroid Cancer.
    PLoS One. 2016;11:e0162482.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: